The Norris Cotton Cancer Center is a comprehensive cancer center as designated by the National Cancer Institute, with administrative offices located within the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

During the past decade, Norris Cotton Cancer Center conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 81 clinical trials were completed, i.e. on average, 352.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 25 clinical trials were completed. i.e. 357.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Norris Cotton Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 84 trials, followed by "Radiation Therapy Oncology Group" with 63 trials sponsored, "Children's Oncology Group" with 44 trials sponsored, "Dartmouth-Hitchcock Medical Center" with 35 trials sponsored and "Eastern Cooperative Oncology Group" with 35 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norris Cotton Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 253 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator, "SWOG Cancer Research Network" with 18 trials as a collaborator and "Eastern Cooperative Oncology Group" with 13 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Norris Cotton Cancer Center" are "Lung Cancer" (32 trials), "Breast Cancer" (31 trials), "Leukemia" (31 trials), "Lymphoma" (28 trials) and "Prostate Cancer" (24 trials). Many other conditions were trialed in "Norris Cotton Cancer Center" in a lesser frequency.

Most popular intervention types in "Norris Cotton Cancer Center" are "Drug" (239 trials), "Radiation" (106 trials), "Biological" (90 trials), "Procedure" (69 trials) and "Other" (33 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (70 trials), "cyclophosphamide" (38 trials), "filgrastim" (35 trials), "etoposide" (34 trials) and "cisplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Norris Cotton Cancer Center" are 268 trials for "All" genders, 33 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are NaN active trials in "Norris Cotton Cancer Center". undefined are not yet recruiting, 5 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 266 completed trials in Norris Cotton Cancer Center, undefined suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Norris Cotton Cancer Center, 45 "Phase 1" clinical trials were conducted, 149 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".

Norris Cotton Cancer Center has several departments that took part in Clinical trials: "Norris Cotton Cancer Center-North" - 92 trials, "Norris Cotton Cancer Center-Manchester" - 55 trials, "Norris Cotton Cancer Center-Nashua" - 45 trials, "Norris Cotton Cancer Center at Dartmouth Medical School" - 9 trials, "Dartmouth-Hitchcock Medical Center Hematology/Oncology" - 2 trials, "Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center" - 2 trials